ADPT 8-K 2026-01-12

Adaptive Biotechnologies Corp (ADPT) 8-K dated 2026-01-12 — accession 0001193125-26-009840. This URL is the filing, not the ADPT hub.

Adaptive Biotechnologies Corp (ADPT) is a diagnostics & research company listed on NASDAQ.

Adaptive Biotechnologies Corp filed a 8-K on 2026-01-12. Accession 0001193125-26-009840.

Cached items: 2.02, 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported ADPT revenue for 2025-12-31 was $277.0M. Net income was -$59.5M. Revenue was up 54.8% from 2024-12-31 to 2025-12-31. ADPT currently screens at market cap $2.69B.

Not investment advice. The ADPT SEC hub lists recent forms. The stock page is the research view.